Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Liminal BioSciences Inc.
LMNL
Healthcare
Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed...
for trading on the Nasdaq Global Market.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LMNL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Comment by
GunnerG
on Jan 22, 2023 4:30pm
RE:RE:RE:RE:They got rid of their best scientists and their team ie lynn
Well the PVR was sold for $105M of which LMNL gave 30% away to Kedron. AKA we go ~$73M. Then we paid off the debt to SALP ~$40M if I recall. The balance has been slowly pi$$ed away. Robbed
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Jan 22, 2023 10:28am
RE:RE:RE:They got rid of their best scientists and their team ie lynn
We have been robbed! what happened to the 90million from the Orphan Drug ???
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2)
•••
37minus4
X
View Profile
View Bullboard History
Comment by
37minus4
on Jan 19, 2023 5:02pm
RE:RE:They got rid of their best scientists and their team ie lynn
Speaking of that lawsuit, i went to the Superior Court of Quebec website and could not find one single thing mentioning Prometic, Liminal, Thomvest etc. Seriously, does anyone have a link or any
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 19, 2023 4:39pm
New Press Release - Liminal BioSciences to Present at BIO CEO & Investor Conference
LAVAL, QC and CAMBRIDGE, England, Jan. 19, 2023 /CNW/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at Liminal BioSciences is scheduled to present a company overview on Tuesday February 7, 2023 at 10...
read article.
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Comment by
stockbuphoon
on Jan 17, 2023 12:15pm
RE:They got rid of their best scientists and their team ie lynn
Liminal have purposely buried 4050 (it was their flagship of the entire company strategy being pumped with 5 different organs showing efficacy according to Bruce, Pierre and John Moran) and are
...more
(1)
•••
hankman
X
View Profile
View Bullboard History
Post by
hankman
on Jan 16, 2023 10:15pm
test
test
(263)
•••
sollmg
X
View Profile
View Bullboard History
Comment by
sollmg
on Jan 16, 2023 6:38pm
RE:Ryplazim
And you can by it anywhere https://insiderx.com/drugs/ryplazim/prices
(263)
•••
sollmg
X
View Profile
View Bullboard History
Post by
sollmg
on Jan 16, 2023 6:35pm
Ryplazim
Nice to see it made the market https://www.ryplazim.com/
(6)
•••
edrose
X
View Profile
View Bullboard History
Post by
edrose
on Jan 15, 2023 3:17pm
They got rid of their best scientists and their team ie lynn
Lynne gagnon when they wiped out retail investors and stated we are cancelling research stating all data was not significant and stated selling assets what have they done since 2019 to increase
...more
(1)
•••
VerylongPLI
X
View Profile
View Bullboard History
Comment by
VerylongPLI
on Jan 13, 2023 8:08am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Trough
As one of the idiots who rode this all the way up and all the way down, I get it. I understand the pain of those ill-equipped to bear the losses. It is not a pleasant outcome after all of the hype and
...more
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Comment by
stockbuphoon
on Jan 12, 2023 4:15pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Trough
GunnerG, you're still here criticizing all of the people who believed in this company and lost a ton of their life savings because you were right and someone on a chat board was being rude to you?
...more
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Comment by
GunnerG
on Jan 06, 2023 6:13pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Trough
OMG, the action is frivolous, not the amount. Big difference and it's that attitude that got you, and many others, in over your head. Me, one of a select few, now thats funny. There
...more
(6)
•••
thePlayer
X
View Profile
View Bullboard History
Post by
thePlayer
on Jan 06, 2023 5:59pm
31 cents? Seriously?
I guess there is a chance that some "investors" are still putting cash into this disgust. Will try to be polite - those folks must be, as a minimum, completely blind, deaf and half or more
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 06, 2023 4:05pm
New Press Release - Liminal BioSciences Announces Priorities For 2023
Closed December 2022 with just over CAD 37 million cash on hand, expecting to provide a runway into early 2024.Plans to divest its remaining non-core assets, to further extend runway.Nominated LMNL6511 as its GPR84 Antagonist lead preclinical drug candidate.Selection of initial target indication...
read article.
(199)
•••
PLITheOne
X
View Profile
View Bullboard History
Comment by
PLITheOne
on Jan 06, 2023 12:44pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Trough
A billion dollar lawsuit against Liminal is not frivolous! If you are genuinely interested you can find this claim filed at the Superior Court of Quebec. Curious, as a long time invester, who
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >